跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
mucosal vaccine
首页
药物
mucosal vaccine
mucosal vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
NOVEL, NON-ANTIGENIC, MUCOSAL ADJUVANT FORMULATION WHICH MODULATES THE EFFECTS OF SUBSTANCES, INCLUDING VACCINE ANTIGENS, IN CONTACT WITH MUCOSAL BODY SURFACES
US 2012014991 A1
申请人: RAA JAN
优先权: 2000
CN
US
4 件公开
MUCOSAL VACCINE USING CATIONIC NANOGEL
US 2011206729 A1
申请人: AKIYOSHI KAZUNARI
优先权: 2008
EP
US
4 件公开
Use of hyaluronic acid polymers for mucosal delivery of vaccine and adjuvants
US 2005226937 A1
申请人: CHIRON CORP
优先权: 2000
US
4 件公开
VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION
US 2014220079 A1
申请人: NITTO DENKO CORP
优先权: 2013
CN
EP
US
3 件公开
US 2014234377 A1
申请人: NITTO DENKO CORP
优先权: 2013
CN
US
2 件公开
VACCINE COMPOSITION FOR TRANSDERMAL OR MUCOSAL ADMINISTRATION
US 2014220058 A1
申请人: NITTO DENKO CORP
优先权: 2013
CN
EP
US
3 件公开
A BACTERIOPHAGE-BASED, NEEDLE AND ADJUVANT-FREE, MUCOSAL COVID-19 VACCINE
EP 4514386 A4
申请人: UNIV AMERICA CATHOLIC
优先权: 2022
EP
US
WO
3 件公开
Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity
US 2007219149 A1
申请人: TORAY INDUSTRIES
优先权: 2003
CN
US
3 件公开
Mucosal vaccine adjuvants containing bacterial flagellins as an active component
US 7914802 B2
申请人: UNIV NAT CHONNAM IND FOUND
优先权: 2004
CN
US
3 件公开
Antigen-drug vehicle enabling transmucosal and transdermal administration, and method of inducing mucosal immunity and mucosal vaccine and DDS using the same
US 8268321 B2
申请人: KIDO HIROSHI
优先权: 2004
CN
US
3 件公开
Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies
US 8211442 B2
申请人: KIDO HIROSHI
优先权: 2005
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈